Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1999-01-20
2000-07-18
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514451, 514461, 514467, 514520, 514821, 514824, 514825, 549426, 549451, 549491, 562621, 562623, 558411, A61K 3116, C07C23908
Patent
active
060908521
ABSTRACT:
Compounds of formula (I): ##STR1## where the substituents are as defined herein, and salts thereof, are matrix metalloprotease inhibitors.
REFERENCES:
patent: 5932595 (1999-08-01), Bender et al.
Beckett, R.P., et al., 1996, DDT 1(1):16-26, "Recent advances in matrix metalloproteinase inhibitor research".
Beckett, R.P., 1996, Exp. Opin. Ther. Patents 6(12):1305-1315, "Recent advances in the field of matrix metalloproteinase inhibitors".
Zask, A., et al., 1996, Curr. Pharm. Design 2:624-661, "Inhibition of matrix metalloproteinases: structure based design".
Dack Kevin Neil
Whitlock Gavin Alistair
Ginsburg Paul H.
Koller Alan L.
Kumar Shailendra
Pfizer Inc
Richardson Peter C.
LandOfFree
Substituted alpha-aminosulphonyl-acetohydroxamic acids as therap does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted alpha-aminosulphonyl-acetohydroxamic acids as therap, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted alpha-aminosulphonyl-acetohydroxamic acids as therap will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2037585